3 Followers on Owler
OverviewFundingNews & Insights

Antag Therapeutics Funding History

Since Antag Therapeutics was founded in 2017, it has participated in 2 rounds of funding. In total Antag Therapeutics has raised $87.0M. Antag Therapeutics' last funding round was on Dec 2024 for a total of $84.0M.

Antag Therapeutics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series A
Dec 2024
$84M
6
Versant Ventures,  Novo Holdings,  Export and Investment Fund of Denmark,  Longview Ventures,  SR One,  Pictet
Series A
Jun 2017
$3M
1
Novo Seeds

Total Funding: $87M

Antag Therapeutics Investors

Unlock 4 more investors →

INVESTOR

ROUND

FUNDING DATE

Versant Ventures
Series A
Dec 2024
Novo Holdings
Series A
Dec 2024
Export and Investment Fund of Denmark
Series A
Dec 2024
Longview Ventures
Series A
Dec 2024
SR One
Series A
Dec 2024

Total Investors: 7

Antag Therapeutics has 7 investors, including Versant Ventures, Novo Holdings and Export and Investment Fund of Denmark. The latest investment occurred in Dec 2024.